Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humintech is a private German biotechnology and manufacturing company focused on the research, development, and industrial production of humic substances and humic acids. Its core business is supplying humic-acid-based products for agriculture, including soil conditioners, plant fortifiers, and related biostimulant products. The company also describes applications for its products in environmental technology, water purification, soil decontamination, animal feed, and certain industrial and pharmaceutical-related uses. Humintech appears to operate as a commercial products company rather than a drug-development biotech, with an emphasis on humic matter derived from leonardite and related raw materials. For a biotech analyst, the key point is that this is not a therapeutic drug pipeline company but a specialty humic-substances producer serving agriculture and adjacent sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Humintech.